FDA

An ampule of Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues. Photo :Reuters
USA

FDA expands use of remdesivir to patients with high risk of hospitalization

A health worker prepares a booster dose of a coronavirus disease (Covid-19) vaccine, as vaccinations jump in Italy after the government made inoculation mandatory for all workers, in Rome, Italy. Photo: Reuters
Coronavirus chronicle

US FDA may approve Covid-19 booster without outside advisory panel opinion -CNN

Vials of the Pfizer-BioNTech Covid-19 vaccine sit in a cooler before being thawed at a pop-up Covid-19 vaccination site in the Bronx borough of New York on Tuesday, Jan. 26, 2021. On Tuesday, Nov. 9, 2021, Pfizer asked US regulators to allow boosters of its Covid-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of the coronavirus with holiday travel and gatherings. Photo: UNB/AP
Coronavirus chronicle

Pfizer asks FDA to OK Covid-19 booster shots for all adults

REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Moderna says FDA needs more time to complete review of its Covid-19 shot for adolescents

Photo :Reuters
Coronavirus chronicle

US FDA authorizes first Covid-19 shot for young kids

A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
Coronavirus chronicle

US FDA advisers back Pfizer/BioNTech Covid-19 vaccine for children

A woman holds a small bottle labelled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
Coronavirus chronicle

FDA says benefits outweigh risks for Pfizer/BioNTech Covid-19 vaccine in children

A medical worker displays a vial with a coronavirus disease (Covid-19) vaccine at a vaccination centre in Tehran, Iran Sept 20, 2021. Majid Asgaripour/REUTERS
Coronavirus chronicle

Second J&J Covid shot gets expert backing; FDA looking at lowering age for Pfizer booster

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
USA

US FDA gives marketing nod to an e-cigarette for the first time

The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, US, July 12, 2018. REUTERS/Brendan McDermid
Coronavirus chronicle

Merck seeks first US FDA authorisation for Covid-19 tablet

A parent walks their children on the first day of school, amid the coronavirus (Covid-19) pandemic, at West Tampa Elementary School in Tampa, Florida, US, August 10, 2021. Photo :Reuters
Coronavirus chronicle

US could authorize Pfizer Covid-19 shot for kids age 5-11 in October -sources

Representational Image. Photo/ AFP via Getty Images via The Independent
Analysis

Are Covid boosters needed? FDA vaccine advisers wrestle with a thorny issue

Rabbur Reza , COO of Beximco Pharmaceuticals Ltd
Panorama

“If we can develop skilled manpower, we can enter any market of the world”